• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Grants
    • Partners
    • NCSG Bylaws
JOIN NOW
✕
Categories
  • Nonalcoholic Steatohepatitis
Tags
  • Nonalcoholic Steatohepatitis (NASH)
Study title Alpine-4: Evaluation of Efficacy, Safety and Tolerability of NGM282 (Aldafermin) in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study in Subjects with Compensated Cirrhosis Due to NASH
Disease or condition NAFLD/NASH with Fibrosis and Cirrhosis
Study type Interventional (Clinical Trial)
Intervention/treatment NGN282 (Aldafermin) or Placebo
Phase 2b
Study site Duke University
Study location Durham, NC
Principal investigator Manal Abdelmalek, MD; manal.abdelmalek@duke.edu
Study coordinator Lauren Roberson; lauren.roberson@duke.edu
Phone contact (919) 681-9591
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT04210245

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN NOW